MannKind Corporation

MNKD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $74.9M $46.3M $238.5M $69.8M $124.2M $67.0M $29.9M $71.2M
Accounts Receivable $38.4M $11.8M $14.9M $16.8M $4.7M $4.2M $3.5M $4.0M
Inventory $35.3M $27.9M $28.5M $21.8M $7.2M $5.0M $4.2M $3.6M
Total Current Assets $291.6M $268.3M $373.4M $234.9M $219.5M $79.5M $60.8M $81.9M
Property, Plant & Equipment $82.4M $85.4M $84.2M $45.1M $36.6M $25.9M $26.8M $25.6M
Goodwill $67.6M $1.9M $1.9M $2.4M — — — —
Intangible Assets (Excl. Goodwill) $5.1M $5.3M $1.1M $1.2M — — — —
Total Assets $792.2M $393.8M $475.2M $295.3M $321.2M $108.6M $93.7M $107.7M
Liabilities
Accounts Payable $9.0M $6.8M $9.6M $11.1M $7.0M $5.6M $4.8M $5.4M
Total Current Liabilities $171.0M $81.8M $104.1M $67.3M $48.3M $73.7M $65.6M $75.2M
Long-Term Debt $354.6M $36.1M $268.7M $273.5M $281.2M $122.2M $118.9M $102.5M
Total Liabilities $843.2M $472.7M $721.4M $545.8M $530.5M $289.0M $284.3M $282.8M
Stockholders' Equity
Retained Earnings $-3.20B $-3.20B $-3.23B $-3.22B $-3.13B $-3.05B $-2.99B $-2.94B
Total Stockholders' Equity $-51.0M $-78.8M $-246.2M $-250.5M $-209.3M $-180.4M $-190.5M $-175.1M
← Newer Page 1 of 2 Older →